Hemispherx Biopharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Hemispherx Biopharma Inc
CIK #0000946644
EDGAR Form CIK 2011 - 2026
10-K [0000946644]
10-Q [0000946644]
3 [0000946644]
4 [0000946644]
8-K [0000946644]
D [0000946644]
SC 13D [0000946644]
SC 13G [0000946644]
Form 13D/13G Filer Form 13D/13G Subject Filed
Intracoastal Capital LLC Aim Immunotech Inc [2026-05-27]
ORCA Capital AG Aim Immunotech Inc [2026-05-12]
Armistice Capital LLC Aim Immunotech Inc [2024-11-14]
Deutsch Todd Aim Immunotech Inc [2023-07-27]
Hudson Bay Capital Management LP Aim Immunotech Inc [2020-01-31]
Anson Funds Management LP Aim Immunotech Inc [2019-09-30]
Equels Thomas K Hemispherx Biopharma Inc [2019-06-28]
Equels Thomas K Hemispherx Biopharma Inc [2019-04-09]
Iliad Research & Trading LP Hemispherx Biopharma Inc [2019-04-05]
Sabby Management LLC Hemispherx Biopharma Inc [2018-04-24]
View All
Form 3/4/5 Subject 2011 - 2026
Hemispherx Biopharma Inc
Equels Thomas K
Chemerow David I
Kellner Ted D
Mitchell William M
Rodino Peter W III
Bryan Nancy
Appelrouth Stewart
Lintal Ellen M
Dickey Robert IV
Strayer David R
Springate Wayne S
Pascale Adam
Kiani IRAJ Eqhbal
Carter William A
Cavalli Ralph Christopher
Piani Richard
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hemispherx Biopharma Inc AIM
Series G Convertible Preferred Stock · derivative
2026-03-12 Conversion 25 $0.00
Hemispherx Biopharma Inc AIM
Common stock
2026-03-12 Conversion 25,000 $0.00
Hemispherx Biopharma Inc AIM
Series G Convertible Prefered Stock · derivative
2026-03-12 Conversion 25 $0.00
Hemispherx Biopharma Inc AIM
Common Stock
2026-03-12 Conversion 25,000 $0.00
Hemispherx Biopharma Inc AIM
Class G Warrants · derivative
2026-03-06 Other 50,000 $0.00
Hemispherx Biopharma Inc AIM
Series G Convertible Preferred Stock · derivative
2026-03-06 Other 25 $25,000.00 625,000
Hemispherx Biopharma Inc AIM
Class G Warrants · derivative
2026-03-06 Other 50,000 $0.00
Hemispherx Biopharma Inc AIM
Series G Convertible Preferred Stock · derivative
2026-03-06 Other 25 $25,000.00 625,000
Hemispherx Biopharma Inc AIM
Common Stock
2026-02-05 Grant 2,800 $1.23 3,444
Hemispherx Biopharma Inc AIM
Common Stock
2025-06-13 Buy 107 $7.70 824
Hemispherx Biopharma Inc AIM
Common Stock
2025-06-12 Buy 103 $8.70 896
Hemispherx Biopharma Inc AIM
Common Stock
2025-04-11 Buy 1,968,504 $0.03 59,055
Hemispherx Biopharma Inc AIM
Common Stock
2025-04-11 Buy 196,851 $0.03 5,906
Hemispherx Biopharma Inc AIM
Common Stock
2025-04-11 Buy 1,968,504 $0.03 59,055
Hemispherx Biopharma Inc AIM
Common Stock
2025-04-04 Buy 500 $0.09 45
Hemispherx Biopharma Inc AIM
Common Stock
2025-04-04 Buy 41,000 $0.06 2,460
Hemispherx Biopharma Inc AIM
Common Stock
2025-03-14 Grant 44,899 $0.12 5,388
Hemispherx Biopharma Inc AIM
Common Stock
2025-03-14 Grant 44,899 $0.12 5,388
Hemispherx Biopharma Inc AIM
Common Stock
2025-03-14 Grant 44,899 $0.12 5,388
Hemispherx Biopharma Inc AIM
Common Stock
2025-03-05 Buy 50,000 $0.13 6,500
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com